SPBC119.18 Antibody

What is SPBC119.18 and what organism does it originate from?

SPBC119.18 refers to a specific gene/protein found in Schizosaccharomyces pombe (strain 972/ATCC 24843), commonly known as fission yeast. The commercially available antibody against this target (CSB-PA842771XA01SXV) is designed to recognize and bind to the protein product of this gene. S. pombe is a widely used model organism in molecular and cellular biology research, particularly for studying cell cycle regulation, DNA damage responses, and other fundamental cellular processes .

What are the standard applications for SPBC119.18 antibody in research?

While specific application data for SPBC119.18 antibody is limited in the provided search results, standard research applications would include Western blotting, immunoprecipitation, immunofluorescence microscopy, chromatin immunoprecipitation (ChIP), and flow cytometry. The antibody would typically be used to detect, quantify, or localize the SPBC119.18 protein in experimental systems involving S. pombe or related research models. For optimal results, researchers should verify the antibody's validation for specific applications before designing experiments.

What are the recommended storage conditions for SPBC119.18 antibody?

Although specific storage recommendations for SPBC119.18 antibody are not detailed in the search results, antibodies generally require careful handling to maintain functionality. Based on standard practices for similar research antibodies, SPBC119.18 antibody would likely require storage at -20°C for long-term stability, with aliquoting recommended to avoid repeated freeze-thaw cycles. For working solutions, storage at 4°C for short periods (1-2 weeks) may be appropriate. Specific buffer components for optimal stability should be confirmed with the manufacturer.

How is antibody specificity for SPBC119.18 typically validated?

Antibody validation for research applications typically involves multiple approaches. For SPBC119.18 antibody, validation would likely include Western blot analysis showing a band of the expected molecular weight, absence of this band in negative controls (such as knockout strains), immunofluorescence showing expected cellular localization patterns, and possibly validation through mass spectrometry of immunoprecipitated proteins. Researchers should evaluate published validation data and consider performing additional validation specific to their experimental system.

What are the optimal conditions for using SPBC119.18 antibody in Western blot analysis?

For Western blot applications with SPBC119.18 antibody, researchers should consider adapting protocols similar to those used for other S. pombe proteins. Based on methodologies described in related research, preparation of cell lysates under denaturing conditions is recommended. An example protocol would involve:

• Collecting and washing S. pombe cells in mid-logarithmic growth phase

• Lysing cells under denaturing conditions with appropriate protease inhibitors (leupeptin, aprotinin, pepstatin A, and PMSF)

• Running proteins on SDS-PAGE gels followed by transfer to appropriate membranes

• Blocking membranes with 5% non-fat milk or BSA in TBST

• Incubating with primary SPBC119.18 antibody at an optimized dilution (typically 1:1000 to 1:5000)

• Detecting with HRP-conjugated secondary antibodies and ECL systems similar to those described for other S. pombe proteins

For quantification purposes, consider using IRDye secondary antibodies and imaging systems that allow for precise signal measurement, normalizing to appropriate loading controls.

How can SPBC119.18 antibody be effectively used in co-immunoprecipitation experiments?

For co-immunoprecipitation (Co-IP) experiments with SPBC119.18 antibody, researchers should consider the following methodological approach:

• Prepare native cell lysates using non-denaturing lysis buffers containing appropriate protease inhibitors

• Pre-clear lysates with Protein A/G beads

• Incubate lysates with affinity-purified SPBC119.18 antibody (similar to the approach described for Dsc1 antiserum purification)

• Capture antibody-protein complexes with Protein A/G beads

• Wash extensively to remove non-specific interactions

• Elute bound proteins and analyze by Western blotting

For improved specificity, consider coupling the SPBC119.18 antibody to agarose beads using methods like those described for Dsc1 antibody purification, utilizing AminoLink Plus immobilization kits or similar technologies .

What strategies can be used to troubleshoot non-specific binding of SPBC119.18 antibody?

When encountering non-specific binding with SPBC119.18 antibody, consider implementing these troubleshooting strategies:

• Optimize antibody concentration - test a range of dilutions to find the optimal signal-to-noise ratio

• Modify blocking conditions - test different blocking agents (BSA, non-fat milk, normal serum) at various concentrations

• Increase washing stringency - use higher salt concentrations or add mild detergents to washing buffers

• Pre-absorb the antibody with lysates from organisms lacking the target to remove cross-reactive antibodies

• Consider affinity purification of the antibody using methods similar to those described for Dsc1 antiserum

• Validate results with negative controls (such as knockouts or knockdowns of SPBC119.18)

• Test different secondary antibodies to reduce background

Compare results with other S. pombe antibodies to establish expected patterns of specificity within this experimental system.

How should experiments be designed to study SPBC119.18 protein expression under different cellular conditions?

For studying SPBC119.18 expression under varying conditions, consider designing experiments that:

• Establish baseline expression in wild-type cells during normal growth

• Compare expression across different growth phases (lag, log, stationary)

• Examine expression changes in response to stressors (nutrient limitation, oxidative stress, temperature shifts)

• Analyze expression in relevant mutant backgrounds that may affect the biological pathway of interest

A robust experimental design would include:

• Biological replicates (minimum n=3)

• Appropriate time course sampling

• Quantitative Western blotting with normalization to stable reference proteins

• Complementary RNA expression analysis (RT-qPCR)

• Statistical analysis of significance for observed changes

The methodology could be adapted from experimental approaches used for studying other S. pombe proteins under changing conditions, such as the Sre1 and Sre2 cleavage assays described in the search results .

What controls are essential when using SPBC119.18 antibody in immunofluorescence microscopy?

When performing immunofluorescence microscopy with SPBC119.18 antibody, the following controls are essential:

• Primary antibody controls:

  • Negative control: Omit primary antibody to assess secondary antibody specificity

  • Isotype control: Use irrelevant antibody of same isotype to assess non-specific binding

  • Peptide competition: Pre-incubate antibody with immunizing peptide to confirm specificity

• Sample controls:

  • Wild-type cells as positive control

  • SPBC119.18 knockout/knockdown cells as negative control

  • Cells expressing tagged versions (e.g., GFP-fusion) for colocalization studies

• Technical controls:

  • Autofluorescence control: Examine unstained cells

  • Cross-channel bleed-through control: Image single-labeled samples in all channels

For studies involving co-localization with organelle markers, consider approaches similar to those described for Dsc2-GFP and Ost1-mCherry proteins in S. pombe, which were used to evaluate protein localization in cellular compartments .

How can researchers integrate SPBC119.18 antibody data with other -omics approaches?

To integrate SPBC119.18 antibody-based findings with other -omics data, researchers should consider the following methodological framework:

• Correlate protein expression/localization data from antibody studies with:

  • Transcriptomics: RNA-seq or microarray data to assess correlation between mRNA and protein levels

  • Proteomics: Mass spectrometry data for confirmation of antibody specificity and identification of interacting partners

  • Genetic interaction data: Synthetic lethality screens or suppressor analyses

• Implement data integration tools:

  • Pathway analysis software to place findings in biological context

  • Protein-protein interaction databases to predict functional relationships

  • Gene Ontology (GO) term enrichment analysis

• Validate key findings through orthogonal methods:

  • Confirm protein-protein interactions identified in proteomics using co-immunoprecipitation with SPBC119.18 antibody

  • Validate functional predictions through genetic manipulation (e.g., CRISPR/Cas9, RNAi)

This integrative approach allows researchers to build more comprehensive models of SPBC119.18 function within cellular networks and biological processes.

How should researchers interpret variations in SPBC119.18 antibody signal intensity across different experimental conditions?

When interpreting variations in SPBC119.18 antibody signal intensity, researchers should consider:

• Technical variables affecting signal intensity:

  • Antibody lot-to-lot variations

  • Sample preparation differences

  • Exposure time and detection method sensitivity

  • Protein extraction efficiency

• Biological variables affecting protein levels:

  • Cell cycle stage (particularly important in S. pombe studies)

  • Growth conditions and metabolic state

  • Genetic background differences

  • Post-translational modifications affecting epitope accessibility

• Quantification approaches:

  • Normalize to appropriate loading controls

  • Use methods similar to those described for Sre1 quantification, where signals were normalized to Dsc5 and quantified from three independent experiments using specialized imaging software

  • Present data as fold-change relative to control conditions rather than absolute values

  • Include standard deviation or standard error measurements

• Statistical analysis:

  • Apply appropriate statistical tests based on data distribution

  • Consider multiple testing correction for large-scale analyses

  • Interpret p-values in context of effect size and biological significance

What are the potential pitfalls in comparing data obtained using different batches of SPBC119.18 antibody?

Comparing data across different antibody batches presents several challenges that researchers should address methodologically:

• Batch-to-batch variation sources:

  • Changes in antibody affinity or specificity

  • Differences in concentration or purity

  • Variations in the proportion of active antibody molecules

• Mitigation strategies:

  • Include internal standards across all experiments

  • Calibrate new antibody batches against reference samples

  • Maintain consistent experimental conditions

  • Consider bridge testing (testing old and new batches side-by-side)

• Documentation practices:

  • Record lot numbers and acquisition dates

  • Document any changes in experimental protocols

  • Note any observed differences in background or signal-to-noise ratio

• Data normalization approaches:

  • Use relative quantification rather than absolute values

  • Apply batch correction algorithms for large datasets

  • Consider using multiple antibodies targeting different epitopes of the same protein

How should researchers approach contradictory results between SPBC119.18 antibody-based detection and other methods?

When faced with contradictory results between antibody-based detection and other methods, researchers should implement a systematic troubleshooting approach:

• Technical validation:

  • Verify antibody specificity using knockout/knockdown controls

  • Confirm target protein identity using mass spectrometry

  • Assess potential cross-reactivity with related proteins

• Methodological considerations:

  • Different methods may detect different protein states (native vs. denatured)

  • Post-translational modifications may affect epitope recognition

  • Sample preparation differences may explain discrepancies

• Biological explanations:

  • Protein turnover rates may differ from mRNA stability

  • Different subcellular pools of the protein may be detected by different methods

  • Temporal dynamics may lead to apparent contradictions if sampling times differ

• Resolution strategies:

  • Use orthogonal approaches to resolve contradictions

  • Consider tagged protein expression as an alternative detection method

  • Develop hypothesis-driven experiments to explain contradictions

  • Consult published literature for similar contradictions with other S. pombe proteins

What are the considerations for using SPBC119.18 antibody in chromatin immunoprecipitation (ChIP) experiments?

For ChIP applications with SPBC119.18 antibody, researchers should consider these methodological details:

• Crosslinking optimization:

  • Test different formaldehyde concentrations (typically 1-3%)

  • Optimize crosslinking time (typically 10-30 minutes)

  • Consider dual crosslinking with additional agents for improved efficiency

• Chromatin fragmentation:

  • Optimize sonication parameters for S. pombe cells

  • Aim for fragments between 200-500 bp

  • Verify fragmentation efficiency by agarose gel electrophoresis

• Immunoprecipitation conditions:

  • Determine optimal antibody concentration through titration

  • Include appropriate negative controls (IgG, non-specific antibody)

  • Consider pre-clearing chromatin with protein A/G beads

• Washing stringency:

  • Optimize salt concentration in washing buffers

  • Balance between reducing background and maintaining specific interactions

• Data analysis:

  • Use appropriate normalization methods (input, IgG control)

  • Perform statistical analysis across biological replicates

  • Consider genome-wide approaches (ChIP-seq) for comprehensive binding profiles

How can SPBC119.18 antibody be utilized in studying protein-protein interactions in S. pombe?

For studying protein-protein interactions involving SPBC119.18, researchers can implement these methodological approaches:

• Co-immunoprecipitation strategies:

  • Standard Co-IP followed by Western blotting for suspected interaction partners

  • Mass spectrometry analysis of immunoprecipitated complexes for unbiased discovery

  • Reciprocal Co-IP using antibodies against suspected interaction partners

• Proximity-based methods:

  • Proximity ligation assay (PLA) for detecting interactions in situ

  • BioID or APEX proximity labeling combined with SPBC119.18 antibody validation

• Live-cell approaches:

  • Fluorescence resonance energy transfer (FRET) between tagged proteins

  • Bimolecular fluorescence complementation (BiFC) verified by antibody staining

• Validation of interactions:

  • Genetic interaction studies (synthetic lethality, suppressor analysis)

  • In vitro binding assays with recombinant proteins

  • Mutational analysis of interaction interfaces

The approach could be adapted from methods used to study protein interactions in S. pombe, such as those described for studying Dsc E3 ligase activity and Dsc1-Ubc4 interaction .

What methodologies are recommended for studying post-translational modifications of SPBC119.18 using the specific antibody?

For investigating post-translational modifications (PTMs) of SPBC119.18, consider these methodological approaches:

• PTM-specific detection strategies:

  • Immunoprecipitation with SPBC119.18 antibody followed by Western blotting with PTM-specific antibodies

  • Mass spectrometry analysis of immunoprecipitated protein for unbiased PTM mapping

  • Generation of PTM-specific antibodies for direct detection

• Enrichment techniques:

  • Phospho-specific enrichment (IMAC, titanium dioxide)

  • Ubiquitination enrichment (TUBE technology)

  • SUMOylation enrichment (utilizing SUMO-binding domains)

• Functional analysis:

  • Mutagenesis of identified PTM sites to assess functional significance

  • Treatment with inhibitors of specific modifying enzymes

  • Temporal analysis of modifications under different conditions

• Verification approaches:

  • In vitro modification assays

  • Comparison with known PTM sites in related proteins

  • Correlation with predicted modification sites from bioinformatics tools

For studying ubiquitination, researchers might adapt protocols similar to those used for detecting ubiquitinated proteins in S. pombe, utilizing anti-ubiquitin antibodies (such as P4D1) in conjunction with SPBC119.18 antibody .